Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/26/25 19:37 | 3/24/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Hohl Benjamin | CO | O | CFO | 11 | M.dm | 287 | 6.84 | 0 | 42 | 23 | D | |||||||||||||||
3/26/25 19:37 | 3/24/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Hohl Benjamin | CO | O | CFO | 11 | S.dm | -287 | 6.84 | 0 | -42 | 23 | D | |||||||||||||||
3/21/25 17:49 | 3/19/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | O | CHIEF SC | 1 | S | -258 | 20.61 | 0 | -13 | 1,003 | I | |||||||||||||||
3/19/25 17:42 | 3/17/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Kintz Samuel | CO | DO | P,CEO | 1 | S | -260 | 20.83 | 0 | -13 | 990 | I | |||||||||||||||
3/11/25 17:18 | 3/7/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Patel Anish | CO | O | COO | 4 | S.d | -1,014 | 16.00 | 0 | -63 | 337 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |